FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes - Concepedia

Concepedia

Publication | Open Access

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes

DOI Full Paper Access

37

Citations

30

References

2023

Year

Eyleen de Poel, Sacha Spelier, Marne C. Hagemeijer, Peter van Mourik, S.W.F. Suen, Annelotte M. Vonk, Jesse E. Brunsveld, Georgia N. Ithakisiou, Evelien Kruisselbrink, Hugo Oppelaar,

Journal of Cystic Fibrosis

FibrosisFda-approved Drug ScreeningPharmacologyPulmonary FibrosisDrug DevelopmentMedicinePatient-derived OrganoidsDrug Discovery

References

	Year	Citations

Page 1

Page 1